Diabetes is a silent killer—early detection is the only way to win the battle.Taking control of your sugar today means fewer complications tomorrow.A healthy lifestyle is the sweetest gift you can give yourself and your family.Each one of us has the power to prevent diabetes from taking over our lives or loved ones'.
The ICMR-INDIAB study is a comprehensive national survey designed to provide reliable data on the prevalence of diabetes, hypertension, obesity, dyslipidemia, and other non-communicable diseases (NCDs) at both the state and national levels. The findings from this study are expected to help policymakers, health professionals, and stakeholders develop targeted interventions for the prevention and management of diabetes and other NCDs in Jammu and across India.
He credited Prime Minister Narendra Modi with bringing in a preventable healthcare ecosystem in the country, saying before the Covid pandemic, this concept was alien to India.
In the U.S., over one-third of adults have prediabetes, and more than 10 per cent have diabetes, both of which can lead to serious health complications like heart disease, stroke, and nerve damage. Managing blood sugar levels through a healthy diet, regular exercise, and stress management is key to preventing these issues.
The cost of treatment remains a heavy burden, with 64 per cent of users reporting that the cumulative cost of ongoing care, including hospital visits, medications, and home care, poses a significant financial challenge. Additionally, 45 per cent of individuals noted inconsistent insurance coverage, leading to high out-of-pocket expenses, especially for advanced treatments. The economic strain often extends to families, with 39 per cent of users mentioning that family members contribute financially or take time off work to help with caregiving.
Dr Vinay Kumar Bahl, Director, Cardiac Sciences Professor & Senior Consultant Cardiology, Ramaiah Memorial Hospital, emphasises preventive care's significance in reducing the rising burden of cardiovascular diseases. Indians are predisposed to CVDs, but they are now occurring a decade earlier, putting an immense burden on the healthcare system.
A study by Joshi of 1,054 patients in Mumbai found that 34 per cent of Type 2 Diabetes Mellitus (T2DM) patients are at increased risk of cardiovascular complications.
"By age 30, over 40 per cent of women with PCOD get diabetes and as they age, they face a heightened risk of hypertension, heart disease, brain haemorrhages, and even uterine cancer," said Dr Seema Pandey, the founder, adding that this was in addition to PCOD's connection.
City doctors note there has been an increase of over 20% in such cases following the Covid pandemic. Many of these complications go unnoticed until they escalate, putting patients at greater risk of serious infections and limb loss.
According to a report from Indian Council of Medical Research (ICMR), about 10 per cent of Tripura’s population has already been affected by diabetes; second in Northeast after Sikkim with a record of 15 per cent population suffering from high blood sugar.
Novo markets the oral form of semaglutide in India under the brand name ‘Rybelsus’ for treatment of adults with type-2 diabetes. The company is yet to get approval for the injectable form of semaglutide, which is sold globally under the brand names ‘Wegovy’ and ‘Ozempic’.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
